Evaluation of Recombinant Bovine Interleukin-8 (rbIL-8) as a Treatment for Chronic Intramammary Infection in Dairy Cows.

MLA

Peixoto, Phillip M. G., et al. “Evaluation of Recombinant Bovine Interleukin-8 (RbIL-8) as a Treatment for Chronic Intramammary Infection in Dairy Cows.” Antibiotics (2079-6382), vol. 11, no. 8, Aug. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/antibiotics11081029.

APA

Peixoto, P. M. G., Cunha, L. L., Barbosa, L., Coelho Jr., W., Podico, G., Bicalho, R. C., Canisso, I. F., & Lima, F. S. (2022). Evaluation of Recombinant Bovine Interleukin-8 (rbIL-8) as a Treatment for Chronic Intramammary Infection in Dairy Cows. Antibiotics (2079-6382), 11(8), N.PAG. https://doi.org/10.3390/antibiotics11081029

Chicago

Peixoto, Phillip M. G., Lais L. Cunha, Leonardo Barbosa, Wilson Coelho Jr., Giorgia Podico, Rodrigo C. Bicalho, Igor F. Canisso, and Fabio S. Lima. 2022. “Evaluation of Recombinant Bovine Interleukin-8 (RbIL-8) as a Treatment for Chronic Intramammary Infection in Dairy Cows.” Antibiotics (2079-6382) 11 (8): N.PAG. doi:10.3390/antibiotics11081029.